Research
Print page Print page
Switch language
Rigshospitalet - a part of Copenhagen University Hospital
Published

Screening for gestational diabetes in Europe: where do we stand and how to move forward?: A scientific paper commissioned by the European Board & College of Obstetrics and Gynaecology (EBCOG)

Research output: Contribution to journalJournal articleResearchpeer-review

  1. Endometrial scratch injury with office hysteroscopy before IVF/ICSI: A randomised controlled trial

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Predictors of emergency cesarean section in women with preexisting diabetes

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Routine use of antenatal nonstress tests in pregnant women with diabetes-What is the practice?

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. High maternal age at first and subsequent child births in Denmark in the mid-1800s-Letter to the editor

    Research output: Contribution to journalJournal articleResearchpeer-review

  • Katrien Benhalima
  • Peter Damm
  • André Van Assche
  • Chantal Mathieu
  • Roland Devlieger
  • Tahir Mahmood
  • Fidelma Dunne
View graph of relations

The incidence of gestational diabetes (GDM) is rising globally and it represents an important modifiable risk factor for adverse pregnancy outcomes. GDM is also associated with negative long-term health outcomes for both mothers and offspring. Acceptance and implementation of the 2013 World Health Organization (WHO) criteria varies globally and within Europe. There is at present no consensus on the optimal approach to GDM screening in Europe. More uniformity in GDM screening across Europe will lead to an opportunity for more timely diagnosis and treatment for GDM in a greater number of women. More targeted research is necessary to evaluate optimal screening strategies based on the 2013 WHO criteria across different European populations with a focus on implementation strategy. Future research should address these important questions so that solid recommendations for GDM screening can be made to European health organizations based on screening uptake rates, maternal well-being, maternal and neonatal health outcomes, equity and cost-effectiveness. Here we describe the ongoing controversy on GDM screening and diagnosis, and provide an overview of important topics for future research concerning GDM screening in Europe.

Original languageEnglish
JournalEuropean journal of obstetrics, gynecology, and reproductive biology
Volume201
Pages (from-to)192-6
Number of pages5
ISSN0301-2115
DOIs
Publication statusPublished - Jun 2016

    Research areas

  • Journal Article, Review

ID: 49877261